References
- Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123–133.
- Dokoumetzidis A, Macheras P. (2006). A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. Int J Pharm, 321:1–11.
- Macheras P, Iliadis A. (2006). Modeling In Biopharmaceutics, Pharmacokinetics And Pharmacodynamics. Berlin:Springer-Verlag.
- Bezeau M, Endrenyi L. (1986). Design of experiments for the precise estimation of dose-response parameters: the Hill equation. J Theor Biol, 123:415–430.
- D’Argenio DZ. (1981). Optimal sampling times for pharmacokinetic experiments. J Pharmacokinet Biopharm, 9:739–756.
- Endrenyi L, Chan FY. (1981). Optimal design of experiments for the estimation of precise hyperbolic kinetic and binding parameters. J Theor Biol, 90:241–263.
- Foo L, Duffull SB. (2011). Pharmacokinetics in Drug Development: Advances and Applications, vol. 3; chap. 8. Springer.
- Retout S, Mentré F, Bruno R. (2002). Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics. Stat Med, 21:2623–2639.
- Retout S, Mentré F. (2003). Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics. J Biopharm Stat, 13:209–227.
- Elkoshi Z. (1997). On the variability of dissolution data. Pharm Res, 14:1355–1362.
- Noyes AA, Whitney WR. (1897). Uber die Auflosungsgeschwindigkeit von festen Stoffen in ihren eigenen Losungen. Zeitschrift fur Physikalische Chemie 13:689–692.
- Cupera J, Lansky P. (2011). Homogeneous diffusion layer model of dissolution incorporating the initial transient phase. Int J Pharm, 416:35–42.
- Lánský P, Weiss M. (2001). Modeling heterogeneity of properties and random effects in drug dissolution. Pharm Res, 18:1061–1067.
- Mulye NV, Turco SJ. (1995). A simple model based on first order kinetics to explain release of highly water soluble drugs from porous dicalcium phosphate dihydrate matrices. Drug Dev Ind Pharm 21:943–953.
- Cupera J, Lansky P. (2010). Random effects in drug dissolution. Eur J Pharm Sci, 41:430–439.
- Lánský P, Lánská V, Weiss M. (2004). A stochastic differential equation model for drug dissolution and its parameters. J Control Release, 100:267–274.
- Lee JC, Chen DT, Hung HN, Chen JJ. (1999). Analysis of drug dissolution data. Stat Med, 18:799–814.
- Polli JE, Rekhi GS, Augsburger LL, Shah VP. (1997). Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharm Sci, 86:690–700.
- Kervinen L, Yliruusi J. (1993). Modelling S-shaped dissolution curves. Int J Pharm 92:115–122.
- Papadopoulou V, Kosmidis K, Vlachou M, Macheras P. (2006). On the use of the Weibull function for the discernment of drug release mechanisms. Int J Pharm, 309:44–50.
- Gu X, Fediuk DJ, Simons FE, Simons KJ. (2004). Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrine. Drug Dev Ind Pharm, 30:1009–1017.
- Costa P, Sousa Lobo JM. (2003). Evaluation of mathematical models describing drug release from estradiol transdermal systems. Drug Dev Ind Pharm, 29:89–97.
- Lehmann EL, Casella G. (1998). Theory of Point Estimation. New York: Springer-Verlag Inc.
- Cramer H. (1946). Mathematical Methods of Statistics. Princeton: Princeton University Press.
- Rao CR. (1962). Linear Statistical Inference and its Applications. New York: Wiley.
- Endrenyi L, Dingle BH. (1982). Pharmacokinetics during drug development: data analysis and evaluation techniques. Stuttgart: Gustav Fischer Verlag.
- Dokoumetzidis A, Papadopoulou V, Valsami G, Macheras P. (2008). Development of a reaction-limited model of dissolution: application to official dissolution tests experiments. Int J Pharm, 355:114–125.
- Torgerson WS. (1958). Theory and Method of Measurement. New York: Wiley.